People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics CORP | — | Biotechnology | Pre-Seed | $2.4M | $7.0M | 2012 |
EDWARD KELLY HYSLOP at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside EDWARD KELLY HYSLOP on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Phillippe | 1 | 3 |
| KEN PHILLIPPE | 1 | 2 |
| Gary Hayes | 1 | 2 |
| ALEXANDER W. KRANTZ | 1 | 1 |
| GARY W. HAYES | 1 | 1 |
| KENNETH W. PHILLIPPE | 1 | 1 |
| Alexander Krantz | 1 | 1 |
| RANDAL CHASE | 1 | 1 |
| Paul Woodward | 1 | 1 |
| Martin Woodward | 1 | 1 |
| Ben Catalano | 1 | 1 |
| Jean Bellin | 1 | 1 |
| Allen Krantz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.